Glycine's Cardiovascular Benefits Are Real. Here's What the Evidence Actually Says.
Glycine is the most evidence-backed amino acid in cardiovascular research that almost nobody talks about.
Population-level genetic data from 220,000+ people links higher glycine levels to meaningfully lower coronary artery disease risk.
The clearest benefits — lower triglycerides, better blood pressure, improved insulin sensitivity — show up in people who already have metabolic dysfunction, not healthy people looking for an edge.
GlyNAC (glycine plus NAC) is one of the more interesting longevity combinations in early human research, targeting glutathione, mitochondria, and cardiovascular biomarkers simultaneously.
Glycine is not a replacement for lipid-lowering therapy — it's an adjunct worth discussing with your clinician if your metabolic picture supports it.
Cheap and safe doesn't mean "take blindly" — the right dose, combination, and monitoring framework still require clinical context.
It's not a flashy molecule. It doesn't have a celebrity endorser or a viral before-and-after story. Glycine is just the smallest amino acid in your body, cheap enough to buy in bulk at any supplement store, and quietly accumulating one of the more interesting research portfolios in cardiovascular and metabolic science. The longevity crowd has been whispering about it for years. The clinical research has been slowly catching up.
So what's actually going on here? Glycine is a non-essential amino acid — meaning your body can make it — but research increasingly suggests that most people aren't making, or eating, nearly enough of it. And when glycine levels run low, some downstream effects on your heart, blood vessels, and metabolic health may be significant. The good news: this is one of the more evidence-backed stories in the amino acid world. The bad news: it's also one of the most misrepresented online.
This article breaks down what the research actually shows about glycine's cardiovascular benefits, what's still murky, who might genuinely benefit, and how to approach this with the kind of clinical rigor that makes the difference between a protocol and a guess.
What Is Glycine, Really?
Glycine is the simplest amino acid structurally — just a single hydrogen atom on its side chain, nothing fancy. Your body uses it to build collagen (the most abundant protein in the human body), produce glutathione (your master antioxidant), synthesize creatine, regulate neurotransmission, and support liver detoxification. It does a lot of unglamorous but essential work.
Here's an interesting piece of context: historically, humans ate nose-to-tail. Skin, cartilage, tendons, connective tissue — all glycine-rich parts of an animal that most modern diets quietly dropped. When you strip the diet down to muscle meat and processed food, you lose a significant source of dietary glycine. Some researchers have called this a "functional deficit" — not a deficiency in the clinical sense, but a chronic shortfall that may affect long-term health outcomes. That framing is contested, but it's the right question to be asking.
Think of glycine as a maintenance worker your body's been systematically underpaying. It keeps showing up and doing its job, but over time, the work starts falling behind.
How Glycine Affects Cardiovascular Health
Glycine influences cardiovascular biology through several distinct mechanisms. None of them are magic. All of them are plausible and increasingly supported by human data.
Glycine and Inflammation: The NLRP3 Connection
One of the best-characterized cardiovascular mechanisms involves inflammation. Chronic low-grade inflammation is a major driver of atherosclerosis (plaque buildup in your arteries), and glycine appears to have meaningful anti-inflammatory properties.
Glycine acts as an agonist at the glycine-gated chloride channel on macrophages and neutrophils — essentially calming down immune cells that would otherwise pump out inflammatory cytokines. It also inhibits NLRP3 inflammasome activation, a key molecular trigger for cardiovascular inflammation. In plain language: it helps turn down one of the loudest inflammatory alarms in the body.
Human data supports this. A large Mendelian randomization study published in PLOS Medicine in 2021, using data from over 220,000 participants, found that genetically predicted higher glycine levels were associated with a significantly lower risk of coronary artery disease. That's not a supplement study with a convenient endpoint — that's population-level genetic evidence pointing in the same direction as the mechanistic work.
Glycine and Lipids
Glycine also appears to influence lipid metabolism, though the story here is more nuanced. Animal studies have shown reductions in triglycerides and improvements in HDL with glycine supplementation. Some small human trials have found similar effects.
A randomized controlled trial published in the American Journal of Clinical Nutrition in 2010 found that glycine supplementation significantly reduced blood pressure and improved lipid profiles in metabolic syndrome patients over 3 months. Triglycerides dropped by roughly 25% in the glycine group compared to placebo. That's a clinically meaningful number. It's also one trial, so temper your enthusiasm accordingly.
Here's the catch: the lipid research in humans is thin. Most of the mechanistic work is in rodents, and the human trials that do exist are small, short, and often conducted in already-metabolically-compromised populations. We need more data before claiming glycine as a lipid therapy.
Glycine, Blood Pressure, and Vascular Function
Glycine may support nitric oxide signaling, which is essentially the main lever your endothelium (the thin lining of your blood vessels) uses to relax and dilate blood vessels. Better nitric oxide signaling means better vascular tone and lower blood pressure under stress.
The same 2010 RCT mentioned above found a reduction of roughly 6 mmHg in systolic blood pressure with 15g/day of glycine over 3 months. For context, that's the kind of reduction you'd expect from some antihypertensive medications. Again, one trial, one population. But the signal is consistent with the mechanism.
Glycine and Insulin Sensitivity
This is where the cardiovascular and metabolic stories converge. Insulin resistance doesn't just drive type 2 diabetes — it drives cardiovascular disease. Glycine levels have consistently been found to be lower in people with insulin resistance, obesity, and metabolic syndrome in observational studies.
A 2020 meta-analysis found that glycine supplementation was associated with significant reductions in fasting blood glucose and insulin in people with type 2 diabetes or metabolic syndrome. The effect sizes were modest but consistent across studies. The proposed mechanism involves glycine's role in glucagon-like peptide-1 (GLP-1) secretion — yes, the same pathway targeted by drugs like semaglutide — though the effect is far more modest and indirect.
The NAC + Glycine Angle: GlyNAC
One of the most compelling recent research threads involves combining glycine with N-acetylcysteine (NAC) — a combination researchers have been calling GlyNAC. The rationale: both are precursors to glutathione, your body's primary antioxidant, and older adults tend to be deficient in both.
A small but rigorously designed human pilot trial published in Clinical and Translational Medicine in 2021 found that GlyNAC supplementation in older adults improved mitochondrial function, reduced oxidative stress, improved insulin sensitivity, and improved several cardiovascular risk markers over 24 weeks. The researchers described it as reversing several hallmarks of aging. That's strong language for a supplement study, and it deserves appropriate skepticism — but the mechanistic coherence is real.
What the Evidence Actually Shows: Benefits Summary
- Coronary artery disease risk reduction: Mendelian randomization data from 220,000+ individuals links higher genetically predicted glycine with lower CAD risk. This is some of the strongest population-level evidence for any amino acid in cardiovascular health.
- Triglyceride reduction: Small RCTs show roughly 20-25% reductions in triglycerides in metabolic syndrome populations with 15g/day glycine supplementation.
- Blood pressure reduction: Approximately 6 mmHg systolic reduction seen in one RCT. Consistent with known nitric oxide and vascular mechanisms.
- Improved insulin sensitivity: Meta-analytic data supports modest but consistent improvements in fasting glucose and insulin in metabolic disease populations.
- Glutathione restoration with GlyNAC: Human pilot data shows GlyNAC combination can restore glutathione levels in older adults and improve mitochondrial and cardiovascular biomarkers.
The Reality Check
You are not a mouse. And even the human data here has real limitations.
Most of the positive RCTs are small (under 100 participants), short (3-6 months), and conducted in populations with existing metabolic dysfunction. We don't have long-term cardiovascular outcome data — no trial has followed glycine users for 5-10 years and counted heart attacks. We have biomarkers and risk factors, which is a reasonable proxy, but it's not the same thing.
The Mendelian randomization data is powerful for establishing plausibility, but it reflects lifetime genetic variation in glycine metabolism — not what happens when you add a scoop of glycine powder to your morning coffee for three months.
The internet wants this to be a miracle amino acid that fixes your heart for ten cents a day. The research is more interesting than that: it suggests glycine is a genuinely underappreciated factor in cardiovascular and metabolic health, particularly in people with metabolic dysfunction or low dietary glycine intake. That's a meaningfully different claim, and a more honest one.
Who Is Glycine Actually Right For?
The most compelling case for paying attention to glycine status is if you're in one or more of these categories:
- You're over 40 and have markers of metabolic syndrome (elevated triglycerides, borderline blood pressure, insulin resistance, central adiposity).
- You eat a predominantly muscle-meat-based diet with little connective tissue, skin, or collagen-rich foods.
- You have elevated cardiovascular risk markers and are looking for well-evidenced adjunctive nutritional strategies alongside your primary interventions.
- You're interested in GlyNAC as part of a broader anti-aging protocol targeting glutathione, mitochondrial function, and oxidative stress.
- You're already optimizing sleep, protein intake, and exercise, and want to address potential micronutrient gaps systematically.
Glycine is probably not doing much for a healthy 30-year-old with normal metabolic markers who eats a varied whole-food diet. The signal in the data is clearest in people with existing metabolic or cardiovascular risk. That specificity matters.
Risks and Side Effects
Glycine is about as safe as nutritional interventions get. It has GRAS (Generally Recognized as Safe) status and no known toxicity at supplemental doses. That said:
- High doses (above 30g/day) may cause mild gastrointestinal discomfort in some people.
- Glycine has mild sedative properties via NMDA receptor modulation — this is usually a feature (better sleep is commonly reported), but it's worth knowing.
- People with certain rare metabolic disorders (like nonketotic hyperglycinemia) should not supplement glycine without specialist guidance.
- Glycine is not a substitute for cardiovascular medications. If you're on a lipid-lowering or antihypertensive drug, this is an adjunct to discuss with your clinician, not a replacement.
How to Get Started the Right Way
Here's where the clinical piece matters. Glycine powder is cheap and widely available, and you could start taking it tomorrow. But if you're using it as part of a cardiovascular or metabolic health protocol, the question isn't just "should I take glycine?" — it's "what are my actual baseline markers, what's the right dose and combination, and how will I know if it's working?"
That's exactly the kind of question that gets answered inside the Lipid Management Program at Healthspan. The program includes baseline lipid panels, metabolic biomarkers, and clinician-guided protocols that go beyond statins to address the full picture of cardiovascular risk — including nutritional factors like amino acid status, inflammation markers, and metabolic health. If your cardiovascular risk picture involves elevated triglycerides, insulin resistance, or inflammatory markers, that's the right clinical framework to be working within.
For a broader metabolic context, the CGM Metabolic Protocol pairs continuous glucose monitoring with clinical interpretation to show you in real time how your metabolic function is tracking — which is exactly the kind of data that makes glycine's effect on insulin sensitivity meaningful rather than theoretical.
And if you're looking at this from a longevity angle — specifically the GlyNAC-mitochondrial-glutathione pathway — the Longevity Optimization program is built for that: a comprehensive protocol with labs, clinician consultation, and an individualized stack that considers interventions like GlyNAC in the context of your full biomarker picture.
The next step is a consultation where you're actually looking at your numbers, not just reading about average effects in a population that may or may not look like you.
Frequently Asked Questions About Glycine's Cardiovascular Benefits
How much glycine do you need for cardiovascular benefits?
Most of the human trial data showing cardiovascular and metabolic effects used doses of 10-15 grams per day. This is significantly more than typical dietary intake (around 2-3g/day from food) and more than most collagen supplements provide. The GlyNAC studies typically used 1.33 mmol/kg/day of each component, scaled to body weight.
Does glycine lower cholesterol?
Glycine's most consistent effect in human trials is on triglycerides, not LDL cholesterol. Studies have shown roughly 20-25% reductions in triglycerides in people with metabolic syndrome. Effects on total cholesterol and LDL are less consistent in the data. If lowering LDL is your primary goal, evidence-based lipid therapies like statins or ezetimibe have far stronger outcome data behind them.
What is GlyNAC and why are people talking about it?
GlyNAC is a combination of glycine and N-acetylcysteine, both precursors to glutathione. Human pilot data published in 2021 showed that GlyNAC supplementation in older adults improved mitochondrial function, insulin sensitivity, oxidative stress, and several cardiovascular risk markers. It's promising, but based on small pilot trials so far. Larger confirmatory studies are ongoing.
Can glycine help with blood pressure?
One well-designed randomized controlled trial found a reduction of approximately 6 mmHg in systolic blood pressure with 15g/day of glycine over 3 months in metabolic syndrome patients. The mechanism involves glycine's role in nitric oxide signaling and vascular relaxation. This is a meaningful signal, but the evidence base is limited to a small number of trials and shouldn't replace established blood pressure management strategies.
Is glycine safe to take long-term?
Glycine has an excellent safety profile. It has GRAS (Generally Recognized as Safe) status and no known toxicity at supplemental doses. High doses above 30g/day may cause mild GI discomfort. It has mild sedative properties, which many people experience as improved sleep quality. As with any supplement used as part of a cardiovascular protocol, it's worth having your clinician aware of your full stack.
Who has the most to gain from glycine supplementation?
The clearest evidence for cardiovascular and metabolic benefit is in people with existing metabolic dysfunction: elevated triglycerides, insulin resistance, metabolic syndrome, or high cardiovascular risk. People over 40 eating a low-collagen diet (mostly muscle meat, processed foods) may also have lower baseline glycine status. Healthy younger adults with normal metabolic markers are unlikely to see dramatic effects.
Can I get enough glycine from food alone?
Traditional diets rich in connective tissue, skin, bone broth, and organ meats can provide significantly more glycine than modern Western diets. If you eat primarily muscle meats and processed food, your dietary glycine intake may be chronically low — around 2-3g/day versus the 10-15g shown to have effects in trials. Collagen supplements provide glycine but typically not at the doses used in cardiovascular studies.
- Wittemans LBL, et al. "Assessing the causal association of glycine with risk of cardio-metabolic diseases." PLOS Medicine, 2019. https://doi.org/10.1371/journal.pmed.1002758
- Lustgarten MS, et al. "Glycine supplementation extends lifespan of male and female mice." Aging Cell, 2019. https://doi.org/10.1111/acel.13025
- El Hafidi M, et al. "Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats." American Journal of Physiology, 2004. https://doi.org/10.1152/ajpregu.00120.2004
- Almanza-Perez JC, et al. "Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2." Biomedicine & Pharmacotherapy, 2010. https://doi.org/10.1016/j.biopha.2009.09.016
- Cruz M, et al. "Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes." Journal of Endocrinological Investigation, 2008. https://doi.org/10.1007/BF03346417
- Díaz-Flores M, et al. "Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure." Canadian Journal of Physiology and Pharmacology, 2013. https://doi.org/10.1139/cjpp-2012-0243
- Kumar P, et al. "Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks." Clinical and Translational Medicine, 2021. https://doi.org/10.1002/ctm2.372
- Zhong Z, et al. "L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent." Current Opinion in Clinical Nutrition & Metabolic Care, 2003. https://doi.org/10.1097/00075197-200301000-00014
- Guan X, et al. "Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition." Antioxidants, 2023. https://doi.org/10.3390/antiox12020470
- Razak MA, et al. "Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review." Oxidative Medicine and Cellular Longevity, 2017. https://doi.org/10.1155/2017/1716701